Haigh Adrian's Form 4/A amendment
AmendedFennec Pharmaceuticals Inc. (FENC) · filed Apr 26, 2024
- Accession no.
- 0001415889-24-011584
- Filed
- Apr 26, 2024
- Trade date
- Apr 15-16, 2024
- Filing delay
- 11 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Apr 16, 2024
This filing lists 2 non-derivative transactions. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $457.3K. It was filed 11 days after the trade.
This amendment restates part of 0001415889-24-010901 (filed Apr 16, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Haigh AdrianCIK 0001717425 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | Common Shares | MOption exerciseAcquired | +22,222 | $2.31 | +$51,332.82 | 22,222 | Direct | |
| Apr 16, 2024 | Common Shares | MOption exerciseAcquired | +22,222 | $2.31 | +$51,332.82 | 44,444 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001415889-24-010901 (filed Apr 16, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | Common Shares | SSaleDisposed | −22,222 | $10.30 | −$228,886.6 | 22,222 | Direct | |
| Apr 16, 2024 | Common Shares | SSaleDisposed | −22,222 | $10.28 | −$228,442.16 | 0 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | Options | MOption exerciseDisposed | −22,222 | $2.31 | −$51,332.82 | 471,357 | Direct | |
| Apr 16, 2024 | Options | MOption exerciseDisposed | −22,222 | $2.31 | −$51,332.82 | 449,135 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On April 16, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 15, 2024, and an additional 22,222 common shares on April 16, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".
- F2
On April 16, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 15, 2024, and an additional 22,222 common shares on April 16, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".